Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ C4795525!4795525!27006639     free     free     free Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Malays+J+Med+Sci 2015 ; 22 (Spec Issue): 62-71 Nephropedia Template TP {{tp|p=27006639|t=2015. Tranexamic Acid as Antifibrinolytic Agent in Non Traumatic Intracerebral Hemorrhages |pdf=|usr=}}{{27006639}} gab.com Text Tranexamic Acid as Antifibrinolytic Agent in Non Traumatic Intracerebral Hemorrhages JO: Malays J Med Sci http://www.kidney.de/pget.php?&tw=1&pmid=27006639 #FOAvip Background: Mortality and morbidity associated with intracerebral hemorrhage is still high. Up to now, there are no evidence-based effective treatments for acute ICH. This study is to assess the effect of tranexamic acid (TXA) on hematoma growth of patients with spontaneous ICH compared to a placebo.Methods: We performed a single-blinded, randomised placebo-controlled trial of TXA (intravenous 1g bolus, followed by infusion TXA 1 g/hour for 8 hours) in acute (< 8 hours) primary ICH. Strict blood pressure control (target SBP 140-160 mmHg). A repeat Computed Tomography brain was done after 24 hours to reassess hematoma growth. The primary objective is to test the effect of TXA on hematoma growth. Other objective was to test the feasibility, tolerability, and adverse events of TXA in primary ICH.Results: Statistical analysis showed significant hematoma growth in control group after 24 hours compared to baseline (14.3300 vs 17.9940, P = 0.001) whereas the treatment group there is no significant hematoma size expansion between baseline and after 24 hours (P = 0.313).Conclusions: This study showed a significant hematoma volume expansion in the control group compared to the treatment group. Twit Text FOAVip Tranexamic Acid as Antifibrinolytic Agent in Non Traumatic Intracerebral Hemorrhages ????Malays J Med Sci http://www.kidney.de/pget.php?&tw=1&pmid=27006639 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27006639 #FOAvip English Wikipedia <ref>{{Cite pmid|27006639}}</ref> Tranexamic Acid as Antifibrinolytic Agent in Non Traumatic Intracerebral Hemorrhages #MMPMID27006639 ARUMUGAM A; A RAHMAN NA; THEOPHILUS SC; SHARIFFUDIN A; ABDULLAH JM Malays J Med Sci 2015[Dec]; 22 (Spec Issue): 62-71 PMID27006639show ga Background: Mortality and morbidity associated with intracerebral hemorrhage is still high. Up to now, there are no evidence-based effective treatments for acute ICH. This study is to assess the effect of tranexamic acid (TXA) on hematoma growth of patients with spontaneous ICH compared to a placebo.Methods: We performed a single-blinded, randomised placebo-controlled trial of TXA (intravenous 1g bolus, followed by infusion TXA 1 g/hour for 8 hours) in acute (< 8 hours) primary ICH. Strict blood pressure control (target SBP 140-160 mmHg). A repeat Computed Tomography brain was done after 24 hours to reassess hematoma growth. The primary objective is to test the effect of TXA on hematoma growth. Other objective was to test the feasibility, tolerability, and adverse events of TXA in primary ICH.Results: Statistical analysis showed significant hematoma growth in control group after 24 hours compared to baseline (14.3300 vs 17.9940, P = 0.001) whereas the treatment group there is no significant hematoma size expansion between baseline and after 24 hours (P = 0.313).Conclusions: This study showed a significant hematoma volume expansion in the control group compared to the treatment group. äTranexamic Acid as Antifibrinolytic Agent in Non Traumatic Intracerebr(epmc).pdf DeepDyve Pubget Overpricing